1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria

Technology appraisal guidance [TA778] Published: 09 March 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 156 KB 09 March 2022  
  • Register of interests PDF 140 KB 09 March 2022  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 201 KB 08 December 2021  
  • Committee papers PDF 6.62 MB 08 December 2021  
  • Public committee slides PDF 461 KB 08 December 2021  

Invitation to participate

  • Final scope PDF 382 KB 12 March 2021  
  • Final stakeholder list PDF 276 KB 12 March 2021  
  • NICE's response to comments on the draft scope and provisional stakeholder list PDF 526 KB 12 March 2021  
  • Equality impact assessment (Scoping) PDF 255 KB 12 March 2021  

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators  
  • Draft scope post referral PDF 200 KB 20 July 2020  
  • Draft matrix post referral PDF 154 KB 20 July 2020